Oramed Pharmaceuticals EBITDA 2012-2025 | ORMP
Oramed Pharmaceuticals ebitda from 2012 to 2025. Ebitda can be defined as earnings before interest, taxes, depreciation and amortization.
|
Oramed Pharmaceuticals Annual EBITDA (Millions of US $) |
|
|---|---|
| 2024 | $-13 |
| 2023 | $-16 |
| 2022 | $-41 |
| 2021 | $-12 |
| 2021 | $-24 |
| 2020 | $-12 |
| 2019 | $-15 |
| 2018 | $-14 |
| 2017 | $-11 |
| 2016 | $-10 |
| 2015 | $-7 |
| 2014 | $-6 |
| 2013 | $-4 |
| 2012 | |
| 2012 | $-3 |
| 2011 | $-1 |
| 2011 | $-2 |
|
Oramed Pharmaceuticals Quarterly EBITDA (Millions of US $) |
|
|---|---|
| 2025-09-30 | $-2 |
| 2025-06-30 | $-2 |
| 2025-03-31 | $-4 |
| 2024-12-31 | $-4 |
| 2024-09-30 | $-3 |
| 2024-06-30 | $-3 |
| 2024-03-31 | $-3 |
| 2023-12-31 | $-4 |
| 2023-09-30 | $-3 |
| 2023-06-30 | $-4 |
| 2023-03-31 | $-5 |
| 2022-12-31 | $-10 |
| 2022-09-30 | $-8 |
| 2022-06-30 | $-11 |
| 2022-03-31 | $-11 |
| 2021-12-31 | $6 |
| 2021-11-30 | $-8 |
| 2021-09-30 | $-7 |
| 2021-08-31 | |
| 2021-06-30 | $-4 |
| 2021-05-31 | $-6 |
| 2021-03-31 | $-7 |
| 2021-02-28 | $-5 |
| 2020-11-30 | $-6 |
| 2020-08-31 | |
| 2020-05-31 | $-2 |
| 2020-02-29 | $-4 |
| 2019-11-30 | $-2 |
| 2019-08-31 | |
| 2019-05-31 | $-4 |
| 2019-02-28 | $-4 |
| 2018-11-30 | $-5 |
| 2018-08-31 | |
| 2018-05-31 | $-5 |
| 2018-02-28 | $-3 |
| 2017-11-30 | $-3 |
| 2017-08-31 | |
| 2017-05-31 | $-2 |
| 2017-02-28 | $-3 |
| 2016-11-30 | $-2 |
| 2016-08-31 | |
| 2016-05-31 | $-2 |
| 2016-02-29 | $-2 |
| 2015-11-30 | $-2 |
| 2015-08-31 | |
| 2015-05-31 | $-2 |
| 2015-02-28 | $-2 |
| 2014-11-30 | $-2 |
| 2014-08-31 | |
| 2014-05-31 | $-2 |
| 2014-02-28 | $-1 |
| 2013-11-30 | $-1 |
| 2013-08-31 | |
| 2013-05-31 | $-1 |
| 2013-02-28 | $-1 |
| 2012-12-31 | |
| 2012-11-30 | $-1 |
| 2012-08-31 | |
| 2012-05-31 | $-1 |
| 2012-02-29 | $-1 |
| 2011-11-30 | $0 |
| 2011-09-30 | |
| 2011-08-31 | |
| 2011-06-30 | $0 |
| 2011-05-31 | $-1 |
| 2011-03-31 | $0 |
| 2011-02-28 | $-1 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $0.140B | $0.001B |
| Oramed Pharmaceuticals, Inc. is a pharmaceutical company operating as a developer of oral drug delivery systems. The Company is developing orally ingestible insulin capsules for the treatment of diabetes as well as delivery solutions for other drugs and vaccines. Oramed Pharmaceuticals, Inc. is headquartered in Jerusalem, Israel. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $210.647B | 24.28 |
| EssilorLuxottica (ESLOY) | France | $144.389B | 0.00 |
| Stryker (SYK) | United States | $137.523B | 27.31 |
| Boston Scientific (BSX) | United States | $135.199B | 30.92 |
| Medtronic (MDT) | Ireland | $126.407B | 17.51 |
| Medline (MDLN) | United States | $58.001B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $48.030B | 0.00 |
| Agilent Technologies (A) | United States | $38.508B | 24.34 |
| ResMed (RMD) | United States | $36.951B | 25.58 |
| GE HealthCare Technologies (GEHC) | United States | $35.909B | 17.17 |
| Koninklijke Philips (PHG) | Netherlands | $27.434B | 17.92 |
| Insulet (PODD) | United States | $19.996B | 62.06 |
| Terumo (TRUMY) | Japan | $19.854B | 22.35 |
| Zimmer Biomet Holdings (ZBH) | United States | $17.202B | 10.73 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $13.668B | 0.00 |
| Baxter (BAX) | United States | $9.962B | 8.04 |
| Sunny Optical Technology (SNPTF) | China | $9.589B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.437B | 30.34 |
| Demant (WILYY) | Denmark | $7.372B | 0.00 |
| Lantheus Holdings (LNTH) | United States | $4.369B | 13.31 |
| Envista Holdings (NVST) | United States | $4.002B | 22.96 |
| BillionToOne (BLLN) | United States | $3.934B | 0.00 |
| ICU Medical (ICUI) | United States | $3.783B | 24.02 |
| Haemonetics (HAE) | United States | $3.281B | 14.60 |
| Prestige Consumer Healthcare (PBH) | United States | $3.114B | 14.20 |
| Shandong Weigao Medical Polymer (SHWGF) | China | $3.099B | 0.00 |
| QuidelOrtho (QDEL) | United States | $2.223B | 14.29 |
| Perrigo (PRGO) | Ireland | $2.077B | 5.20 |
| Neogen (NEOG) | United States | $2.034B | 44.52 |
| LeMaitre Vascular (LMAT) | United States | $1.946B | 39.18 |
| AtriCure (ATRC) | United States | $1.910B | 0.00 |
| Curaleaf Holdings (CURLF) | Canada | $1.683B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $1.665B | 16.63 |
| Green Thumb Industries (GTBIF) | United States | $1.620B | 71.00 |
| AdaptHealth (AHCO) | United States | $1.408B | 20.39 |
| Lumexa Imaging Holdings (LMRI) | United States | $1.398B | 0.00 |
| Kestra Medical Technologies (KMTS) | United States | $1.342B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.192B | 353.71 |
| Capricor Therapeutics (CAPR) | United States | $1.106B | 0.00 |
| Tilray Brands (TLRY) | Canada | $1.019B | 0.00 |
| Maravai LifeSciences Holdings (MRVI) | United States | $0.959B | 0.00 |
| InMode (INMD) | Israel | $0.874B | 9.87 |
| Omeros (OMER) | United States | $0.869B | 0.00 |
| Valneva SE (VALN) | France | $0.841B | 0.00 |
| CeriBell (CBLL) | United States | $0.796B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.568B | 15.40 |
| Cerus (CERS) | United States | $0.476B | 0.00 |
| Verano Holdings (VRNO) | United States | $0.454B | 0.00 |
| Brainsway (BWAY) | Israel | $0.433B | 73.77 |
| Cresco Labs (CRLBF) | United States | $0.429B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.424B | 0.00 |
| SNDL (SNDL) | Canada | $0.415B | 0.00 |
| Evolus (EOLS) | United States | $0.328B | 0.00 |
| Quanterix (QTRX) | United States | $0.328B | 0.00 |
| SEMPERIT AG HLD (SEIGY) | Austria | $0.309B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.278B | 22.12 |
| TriSalus Life Sciences (TLSI) | United States | $0.263B | 0.00 |
| Sanuwave Health (SNWV) | United States | $0.237B | 0.00 |
| Aurora Cannabis (ACB) | Canada | $0.235B | 138.00 |
| TerrAscend (TSNDF) | Canada | $0.228B | 0.00 |
| High Tide (HITI) | Canada | $0.224B | 0.00 |
| Owens & Minor (OMI) | United States | $0.217B | 2.17 |
| Organigram Global (OGI) | Canada | $0.216B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.196B | 17.32 |
| Sanara MedTech (SMTI) | United States | $0.194B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.186B | 0.00 |
| Vireo Growth (VREOF) | United States | $0.178B | 0.00 |
| Accendra Health (ACH) | United States | $0.170B | 1.71 |
| Quipt Home Medical (QIPT) | United States | $0.158B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.154B | 0.00 |
| Apyx Medical (APYX) | United States | $0.147B | 0.00 |
| Fonar (FONR) | United States | $0.116B | 16.87 |
| MacroGenics (MGNX) | United States | $0.111B | 0.00 |
| Jushi Holdings (JUSHF) | United States | $0.110B | 0.00 |
| Exagen (XGN) | United States | $0.107B | 0.00 |
| Biote (BTMD) | United States | $0.103B | 4.52 |
| Sharps Technology (STSS) | United States | $0.063B | 0.00 |
| ImmuCell (ICCC) | United States | $0.059B | 25.08 |
| Nephros (NEPH) | United States | $0.053B | 38.00 |
| Rockwell Medical (RMTI) | United States | $0.050B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.043B | 0.00 |
| Veru (VERU) | United States | $0.041B | 0.00 |
| Modular Medical (MODD) | United States | $0.037B | 0.00 |
| United-Guardian (UG) | United States | $0.030B | 14.93 |
| Bonk (BNKK) | United States | $0.021B | 0.00 |
| Jin Medical (ZJYL) | China | $0.021B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.020B | 0.00 |
| Cellectar Biosciences (CLRB) | United States | $0.015B | 0.00 |
| INLIF (INLF) | China | $0.009B | 0.00 |
| Flora Growth (FLGC) | United States | $0.007B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.007B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.007B | 0.00 |
| Agape ATP (ATPC) | $0.004B | 0.00 | |
| Zynex (ZYXI) | United States | $0.004B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.003B | 0.00 |
| Functional Brands (MEHA) | United States | $0.003B | 0.00 |
| Meihua Medical Technologies (MHUA) | China | $0.002B | 0.00 |
| Akanda (AKAN) | Canada | $0.000B | 0.00 |
| InterCure (INCR) | Israel | $0.000B | 0.00 |
| InVivo Therapeutics Holdings (NVIVQ) | United States | $0.000B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.000B | 0.00 |